Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
1,287 total articles
Patrick J. Orr, Executive Vice President and Chief Revenue Officer of Healthcare Services Group Inc (NASDAQ: HCSG), sold 45,500 shares on February 18, 2026 at $20.54 per share, generating $934,570. On that same day he exercised options to acquire 45,490 shares at various strike prices, a combined exercise value of $665,344. The company posted fourt…
Deborah Stewart, Senior Vice President and Chief Accounting Officer of Aveanna Healthcare Holdings (NASDAQ: AVAH), disposed of 29,815 shares of common stock across three transactions recorded on a Form 4 filed with the Securities and Exchange Commission. The sales, executed between Feb. 17 and Feb. 19, 2026, brought in $220,196 and were reported as…
Aveanna Healthcare Holdings CEO Jeff Shaner sold 461,909 shares of company stock between February 17 and February 19, 2026, generating about $3.4 million in proceeds. The Form 4 filing shows the trades were executed to cover tax obligations tied to vested equity awards. The transactions come as Aveanna raised its fiscal 2025 revenue and net income …
Patrick A. Cunningham, Chief Compliance Officer of Aveanna Healthcare Holdings, Inc. (NASDAQ: AVAH), sold 49,160 shares between February 17 and February 19, 2026, generating roughly $363,068 in proceeds. The insider now directly holds 337,755 shares. The transactions occurred amid company updates to fiscal 2025 revenue and net income guidance and a…
Aveanna Healthcare Holdings Inc. Chief Financial Officer Matthew Buckhalter sold 36,030 shares of common stock between February 17 and February 19, 2026, for a total of $266,097. The disposals were executed to satisfy tax obligations arising from vested equity awards. The transactions occurred amid company guidance upgrades for 2025 and several ana…
MARA Holdings CEO Frederick G. Thiel sold 27,505 shares on February 17, 2026, under a Rule 10b5-1 plan, generating $210,688. The sale occurred amid a 48% decline in MARA’s stock over six months and broader weakness in Bitcoin mining names. Thiel also received 773,861 performance-vested restricted stock units that were certified on February 18, 2026…
Edwin C. Reisz, Chief Administrative Officer of Aveanna Healthcare Holdings, Inc. (NASDAQ: AVAH), sold 161,043 shares across three transactions between February 17 and February 19, 2026, generating proceeds of $1.19 million. The sales were executed to cover tax obligations tied to vested equity awards. Aveanna has also revised its 2025 revenue outl…
MARA Holdings Chief Financial Officer Khan Salman Hassan sold 16,000 shares on February 17 under a pre-arranged Rule 10b5-1 plan for $122,560, then on February 18 received 509,119 performance-vested restricted stock units that vested based on 2025 performance targets. The company's shares trade near a 52-week low amid sector volatility and recent a…
Rhythm Pharmaceuticals' Chief Financial Officer, Hunter C. Smith, sold 8,058 shares of company stock on February 17 and 19, 2026, in transactions executed under a Rule 10b5-1 plan. The trades, which generated roughly $805,813, come as the company reported preliminary fourth-quarter 2025 product revenue growth and attracted several analyst price tar…
John Kent Walker, Alphabet's President of Global Affairs and Chief Legal Officer, sold 46,975 shares of Class C capital stock on February 17, 2026, via the Arete Trust for roughly $14.3 million. The sale occurred as Alphabet shares trade around $302.85, and comes alongside company developments including a withdrawn robotaxi expansion proposal affec…
Arista Networks President and CTO Kenneth Duda sold $4.5 million of company stock on February 17, 2026, under a prearranged 10b5-1 plan, while exercising options to acquire 32,000 shares. The transactions occurred at prices between $141.1477 and $144.74, above the prevailing market price of $137.23. The company reported stronger-than-expected Q4 20…
Pacific Biosciences Chief Operating Officer Mark Van Oene sold 184,897 shares of common stock on February 17 and 18 to cover tax withholding tied to vested restricted stock units. The company reported a fourth-quarter loss narrower than analysts expected and revenue ahead of projections, prompting positive aftermarket activity. Market commentary fr…
John Christopher Shea, Executive Vice President and Chief Administrative Officer of Healthcare Services Group Inc (HCSG), exercised options to acquire 38,857 shares and sold 54,357 shares on February 18, 2026. The disposition generated roughly $1.1 million in proceeds, while the option exercises involved $662,674. The company recently reported a si…
Christian O. Henry, President and CEO of Pacific Biosciences of California, Inc. (NASDAQ: PACB), sold a total of 472,667 shares of common stock on February 17 and 18, 2026, to satisfy tax withholding tied to restricted stock units. The two transactions generated proceeds of about $752,389. After the sales, Henry retains direct ownership of 2,673,50…
Michele Farmer, Chief Accounting Officer at Pacific Biosciences of California, sold 50,167 shares of the company’s common stock on February 17 and 18, 2026, to satisfy tax withholding obligations tied to the vesting of restricted stock units. The transactions totaled about $79,855. Pacific Biosciences recently reported fourth-quarter 2025 results t…
CoreWeave Chief Development Officer Brannin McBee sold 5,624 shares of Class A common stock on February 17, 2026, generating $504,977 in proceeds under a Rule 10b5-1 trading plan. On the same day, McBee converted 5,000 shares of Class B common stock held in trust into Class A shares without a cash exchange. The trades took place amid a stock price …
CoreWeave Chief Development Officer McBee Brannin sold $3.05 million of Class A common stock on February 17, 2026, through two family grantor retained annuity trusts (Canis Major 2025 GRAT and Canis Minor 2025 GRAT). The transactions, executed at weighted-average prices between $89.84 and $95.38, coincided with conversions of Class B shares to Clas…
CoreWeave Chief Development Officer Brannin McBee and an irrevocable trust tied to him sold a combined total of Class A common stock valued at roughly $11.7 million on February 17, 2026. The transactions spanned prices from $89.8366 to $95.38. On the same day McBee and the trust converted substantial amounts of Class B shares into Class A shares. T…
Drew Pinto, Executive Vice President at Marriott International, sold 4,000 shares of Class A Common Stock on February 17, 2026, in a transaction valued at $1.44 million. On the same date he also relinquished restricted units and additional shares to cover tax obligations related to vesting, in a separate set of transactions totaling $1.52 million. …
Upwork General Manager, Marketplace Dave Bottoms sold 32,662 shares of Upwork common stock in transactions on February 18 and February 19, 2026, to meet tax withholding obligations tied to vested equity. The sales, executed at prices in the low-to-mid $13 range, coincided with the stock trading near its 52-week low and a market cap reported at $1.7…
Upwork Inc.'s chief financial officer, Erica Gessert, sold 26,292 shares on February 18, 2026, generating roughly $362,887. The transactions followed option exercises and leave Gessert with just under 300,000 shares directly held. The company concurrently added a $300 million share repurchase authorization, bringing total buyback commitments to $60…
Glenbrook Capital Management boosted its ownership in SenesTech, Inc. (NASDAQ: SNES) via three purchases between February 17 and February 19, 2026, acquiring 85,901 shares for $200,634. The buying coincided with a 20% one-week stock gain, and comes as SenesTech shifts to direct e-commerce sales on Amazon, records e-commerce as over half of 2025 rev…
Roku Inc. executive Jedda Dan sold 3,000 shares of Class A common stock on February 17, 2026, in two trades totaling $266,640 according to a Form 4 filing. The sales were made under a pre-arranged 10b5-1 trading plan. Dan retains direct ownership of 84,267 Roku shares. The insider move comes on the heels of Roku's robust fourth-quarter 2025 financi…
Snowflake Inc. director Frank Slootman sold 105,900 shares of common stock on February 18, 2026, in four transactions totaling roughly $17.7 million, while exercising options to acquire 100,000 shares at $8.88 each. After the trades, Slootman directly holds 50,329 shares and indirectly holds 207,862 shares via trusts. The stock trades at $179.20, d…
Intercontinental Exchange Chief Executive Jeffrey Sprecher sold 279,937 shares on February 18, 2026, for roughly $43.4 million under a Rule 10b5-1 plan, and exercised options to acquire 52,079 shares. The transactions coincide with robust fourth-quarter results for 2025, record open interest across derivatives markets, and product launches includin…
